MedPath

武汉田田药业有限公司

Ownership
-
Established
1997-11-05
Employees
-
Market Cap
-
Website
www.whttyy.cn

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

9

NMPA:9

Drug Approvals

更年灵胶囊

Approval Number
国药准字Z20055365
Approval Date
Feb 3, 2021
NMPA

妇康宝合剂

Approval Number
国药准字Z19983022
Approval Date
Aug 7, 2020
NMPA

复方珍珠口服液

Approval Number
国药准字B20020243
Approval Date
Aug 7, 2020
NMPA

芪归生血胶囊

Approval Number
国药准字B20020083
Approval Date
Aug 7, 2020
NMPA

乳核内消液

Approval Number
国药准字Z19983021
Approval Date
Aug 7, 2020
NMPA

Flunarizine Hydrochloride Oral Solution

Product Name
花欣
Approval Number
国药准字H20020094
Approval Date
Jul 8, 2020
NMPA

美源牌田田珍珠口服液

Approval Number
国食健字G20040216
Approval Date
Jan 21, 2004
NMPA

田田牌福欣胶囊

Approval Number
卫食健字(2001)第0262号
Approval Date
Aug 24, 2001
NMPA

田田润珍珠口服液

Approval Number
卫食健字(2000)第0091号
Approval Date
Feb 16, 2000
NMPA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.